Invention Grant
- Patent Title: Cell-specific internalizing RNA aptamers against human CCR5 and uses therefore
-
Application No.: US14801710Application Date: 2015-07-16
-
Publication No.: US09605266B2Publication Date: 2017-03-28
- Inventor: John Rossi , Jiehua Zhou , Marc Weinberg , Kevin Morris
- Applicant: City of Hope , The Scripps Research Institute
- Applicant Address: US CA Duarte US CA La Jolla
- Assignee: CITY OF HOPE,THE SCRIPPS RESEARCH INSTITUTE
- Current Assignee: CITY OF HOPE,THE SCRIPPS RESEARCH INSTITUTE
- Current Assignee Address: US CA Duarte US CA La Jolla
- Agency: Mintz Levin Cohn Ferris Glovsky and Popeo, P.C.
- Main IPC: C12N15/11
- IPC: C12N15/11 ; A61K48/00 ; C07H21/04 ; C12N15/115
Abstract:
Provided herein are fluoropyrimidine-modified RNA aptamers capable of binding CCR5. The compositions and methods provided herein are, inter alia, useful for the delivery of anti-viral drugs (e.g., siRNAs) and preventing HIV entry into a target cell.
Public/Granted literature
- US20160053265A1 CELL-SPECIFIC INTERNALIZING RNA APTAMERS AGAINST HUMAN CCR5 AND USES THEREFORE Public/Granted day:2016-02-25
Information query
IPC分类:
